The chart below shows the treatments the participants took.
-Acalabrutinib and BSC
-BSC only
89 participants
88 participants
• 100 mg of acalabrutinib
• BSC as decided by the study doctors
• acalabrutinib twice a day for 10 days
• BSC as decided by the study doctors

What happened during this study?
The participants were in the study for about 3.5 months. But, the entire study took 5 months to finish.
The study started in June 2020 and ended in November 2020.